Successful Desensitization to Imiglucerase of an Adult Patient Diagnosed with Type I Gaucher Disease
Successful Desensitization to Imiglucerase of an Adult Patient Diagnosed with Type I Gaucher Disease
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Gaucher disease is the most common lysosomal storage disorder, and enzyme replacement therapy, such as administration of imiglucerase, is the standard therapy. Anaphylaxis to imiglucerase is rarely reported. Here, we report a 26-year-old female who was diagnosed with type 1 Gaucher disease and referred to our Allergy Outpatient Clinic because of an...
Alternative Titles
Full title
Successful Desensitization to Imiglucerase of an Adult Patient Diagnosed with Type I Gaucher Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_339754
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_339754
Other Identifiers
ISSN
1018-2438
E-ISSN
1423-0097
DOI
10.1159/000339754
